Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
6.09
+0.24 (4.10%)
At close: Mar 9, 2026, 4:00 PM EDT
5.98
-0.11 (-1.81%)
After-hours: Mar 9, 2026, 4:34 PM EDT
Aardvark Therapeutics Market Cap
Aardvark Therapeutics has a market cap or net worth of $132.60 million as of March 9, 2026. Its market cap has decreased by -64.05% in one year.
Market Cap
132.60M
Enterprise Value
6.79M
1-Year Change
-64.05%
Ranking
Category
Stock Price
$6.09
Market Cap Chart
Since the IPO on February 13, 2025, Aardvark Therapeutics's market cap has decreased from $342.15M to $132.60M, a decrease of -61.25%. That is a compound annual growth rate of -59.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 127.37M | -55.43% |
| Dec 31, 2025 | 285.77M | -16.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Connect Biopharma Holdings | 138.64M |
| Adagene | 133.85M |
| Oramed Pharmaceuticals | 130.75M |
| Polaryx Therapeutics | 129.72M |
| Spero Therapeutics | 129.58M |
| Cardiff Oncology | 128.53M |
| Alpha Cognition | 125.89M |
| Black Diamond Therapeutics | 122.50M |